Data as of Apr 17
| -0.01 / -1.92%|
The 1 analysts offering 12-month price forecasts for Taxus Cardium Pharmaceuticals Group Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +292.16% increase from the last price of 0.51.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.